Drug Shortage Report for AURO-VALSARTAN HCT
Report ID | 235918 |
Drug Identification Number | 02408120 |
Brand name | AURO-VALSARTAN HCT |
Common or Proper name | AURO-VALSARTAN HCT |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE VALSARTAN |
Strength(s) | 12.5MG 160MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100's |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-12-05 |
Estimated end date | 2025-01-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-12-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v15 | 2024-12-17 | French | Compare |
v14 | 2024-12-17 | English | Compare |
v13 | 2024-12-06 | English | Compare |
v12 | 2024-12-05 | French | Compare |
v11 | 2024-12-05 | English | Compare |
v10 | 2024-12-04 | English | Compare |
v9 | 2024-12-03 | French | Compare |
v8 | 2024-12-03 | English | Compare |
v7 | 2024-12-03 | French | Compare |
v6 | 2024-12-03 | English | Compare |
v5 | 2024-12-03 | French | Compare |
v4 | 2024-12-03 | English | Compare |
v3 | 2024-12-03 | English | Compare |
v2 | 2024-08-26 | French | Compare |
v1 | 2024-08-26 | English | Compare |
Showing 1 to 15 of 15